NCT00236119 arm group eea3a9f9a1d931462dadc56345736b27 [clinicaltrials_resource:NCT00236119/arm-group/eea3a9f9a1d931462dadc56345736b27]
CEP-701 80mg [clinicaltrials_resource:588a9d92a2a4d8c76df4327f1f7dea2e]CEP-701 60mg [clinicaltrials_resource:9b1535ee0f05a581d70ab308efc4ba0f]CEP-701 40mg [clinicaltrials_resource:d0699eb620fc942bba5abe346a151de1]CEP-701 20mg [clinicaltrials_resource:faf83751f997f2a44c0626927078d93b]Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis [clinicaltrials:NCT00236119]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00236119 arm group eea3a9f9a1d931462dadc56345736b27 [clinicaltrials_resource:NCT00236119/arm-group/eea3a9f9a1d931462dadc56345736b27]
Bio2RDF identifier
NCT00236119/arm-group/eea3a9f9a1d931462dadc56345736b27
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a3a9f9a1d931462dadc56345736b27
description [clinicaltrials_vocabulary:description]
Patient Cohort 4
identifier
clinicaltrials_resource:NCT00236119/arm-group/eea3a9f9a1d931462dadc56345736b27
title
NCT00236119 arm group eea3a9f9a1d931462dadc56345736b27
@en
type
label
NCT00236119 arm group eea3a9f9 ...... 3a9f9a1d931462dadc56345736b27]
@en